BioSpace News Archive

Avenue Therapeutics, Inc., a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of central nervous system diseases, announced the pricing of its underwritten public offering of 3,636,365 common and pre-funded units.

Integra LifeSciences Holdings Corporation announced the appointment of Harvinder Singh as executive vice president and president of Integra’s international business.

Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the third quarter 2022 after market close on Thursday, November 3, 2022 at 4:30 PM Eastern Time.

Sonoma Pharmaceuticals, Inc. announced that it will be exhibiting at the CPHI Conference in Frankfurt, Germany on November 1-3, 2022.

Georgia Urology – the largest urology practice in Georgia – welcomes Drs. Vincent DiCarlo, Robert Fisher, and Kanika Searvance to its acclaimed team of providers.

Blueprint Medicines Corporation announced that, effective October 1, 2022, the Compensation Committee of Blueprint Medicines’ Board of Directors granted non-qualified stock options to purchase an aggregate of 11,381 shares of its common stock and an aggregate of 5,688 restricted stock units to eight new employees under Blueprint Medicines’ 2020 Inducement Plan.